Today, the Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) announced that it has received a major grant from the Food & Drug Administration (FDA) in support of biosimilars research. The award provides $1.3 million over two years for a new BBCIC study focused on increasing the efficiency of biosimilar drug development and review.
On August 4, the Department of Health and Human Services released a Notice of Proposed Rulemaking on Nondiscrimination in Health Programs and Activities. In response, AMCP submitted comments on September 29 which applaud the Department's goal to reinstate regulatory protections from discrimination in covered health programs and activities.
Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.
On August 30, AMCP provided comments to the Centers for Medicare and Medicaid Services (CMS) following the agency's request for feedback on ways to strengthen the Medicare Advantage program.
On August 19, AMCP joined a wide coalition of pharmacy organizations in calling on the Department of Health and Human Services to issue a PREP Act declaration that pharmacists, pharmacy students, and pharmacy technicians, as appropriate, can order and administer FDA authorized or approved monkeypox vaccines, testing, and therapeutics.
AMCP mourns the passing of managed care pharmacy icon Judith Cahill. A former CEO of AMCP, Judy led the organization for more than 15 years, growing its membership from 600 to more than 6,000 managed care professionals.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
During AMCP 2022 in March, Dr. Kali Cyrus lead a workshop titled: A Primer on Bias from Discovery to Implementing Strategies to Address. AMCP CEO, Susan Cantrell explores the highlights from this workshop and how managed care professionals may be able to implement Dr. Cyrus' strategies in their day-to-day.